World's Best Scientists 2026 revealed!
Taofeek K. Owonikoko

Taofeek K. Owonikoko

D-Index & Metrics

Medicine

D-Index
73
Citations
21800
World Ranking
19609
National Ranking
9763

Overview

Taofeek K. Owonikoko is a researcher affiliated with Emory University in the United States. They have contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology, with a particular focus on oncology, molecular biology, pulmonary and respiratory medicine, epidemiology, and radiology, nuclear medicine, and imaging.

Their research work addresses several topics, including:

  • Lung Cancer Research Studies
  • Lung Cancer Treatments and Mutations
  • Neuroendocrine Tumor Research Advances
  • Peptidase Inhibition and Analysis
  • Cancer Therapeutics and Mechanisms
  • Cancer Immunotherapy and Biomarkers
  • RNA Modifications and Cancer

They have published notable papers in various high-impact journals. Selected recent papers include:

  • Efficacy of Selpercatinib in RET-Altered Thyroid Cancers (2020), New England Journal of Medicine
  • Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer (2023), New England Journal of Medicine
  • Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy (2020), Frontiers in Oncology
  • Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451 (2021), Journal of Clinical Oncology
  • Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study (2023), Journal of Clinical Oncology

Frequent co-authors collaborating with Taofeek K. Owonikoko include:

  • Suresh S. Ramalingam
  • Bassel F. El-Rayes
  • Nabil F. Saba
  • Keunchil Park
  • Christina Wu

The researcher's publications are often featured in the following venues:

  • Journal of Clinical Oncology
  • Cancer
  • Journal of Thoracic Oncology
  • Cancer Research
  • Annals of Oncology

Best Publications

  • The Immune Landscape of Cancer

    Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Genomic Classification of Cutaneous Melanoma

    Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

  • Integrated Genomic Characterization of Papillary Thyroid Carcinoma

    Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma

    Benjamin J. Raphael;Ralph H. Hruban;Andrew J. Aguirre;Richard A. Moffitt

  • PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma

    Michael R. Migden;Danny Rischin;Chrysalyne D. Schmults;Alexander Guminski

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent

    Alice O. Kamphorst;Andreas Wieland;Tahseen Nasti;Shu Yang;Shu Yang

  • Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

    Adam Abeshouse;Clement Adebamowo;Sally N. Adebamowo;Rehan Akbani

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.

    Alice O. Kamphorst;Rathi N. Pillai;Shu Yang;Tahseen H. Nasti

  • Lung Cancer in Elderly Patients: An Analysis of the Surveillance, Epidemiology, and End Results Database

    Taofeek K. Owonikoko;Camille C. Ragin;Chandra P. Belani;Ana B. Oton

  • Efficacy of Selpercatinib in RET-Altered Thyroid Cancers

    Lori J Wirth;Eric Sherman;Bruce Robinson;Benjamin Solomon

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Lung cancer: New biological insights and recent therapeutic advances.

    Suresh S. Ramalingam;Taofeek K. Owonikoko;Fadlo R. Khuri

  • Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

    Franz X. Schaub;Varsha Dhankani;Ashton C. Berger;Mihir Trivedi

  • Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.

    Taro Hitosugi;Lu Zhou;Shannon Elf;Jun Fan

  • Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.

    M. Catherine Pietanza;Saiama N. Waqar;Lee M. Krug;Afshin Dowlati

Frequent Co-Authors

Suresh S. Ramalingam
Suresh S. Ramalingam Emory University
Fadlo R. Khuri
Fadlo R. Khuri American University of Beirut
Walter J. Curran
Walter J. Curran Emory University
Dong M. Shin
Dong M. Shin Emory University
Shi-Yong Sun
Shi-Yong Sun Emory University
Chandra P. Belani
Chandra P. Belani Penn State Cancer Institute
Xingming Deng
Xingming Deng Emory University
Ramaswamy Govindan
Ramaswamy Govindan Washington University in St. Louis
Sagar Lonial
Sagar Lonial Emory University
Rafi Ahmed
Rafi Ahmed Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Medicine but seeking alternative routes or complementary qualifications, a range of online degrees can open the door to dynamic healthcare careers. Specializing in advanced nursing, healthcare leadership, or administration are all viable options for ambitious professionals wanting flexibility and growth.

Aspiring nurse practitioners may explore the fastest psychiatric nurse practitioner program options to accelerate their path into mental health care—a high-demand field with excellent salary potential. Alternatively, leaning into healthcare management can be achieved through the best online mha programs or by targeting the cheapest mha programs online healthcare for an affordable route into healthcare administration.

Those seeking the highest level of nursing expertise without pausing their careers may opt for advanced programs like the best dnp programs online. Each pathway offers unique opportunities in leadership, clinical practice, and management—enabling you to shape a medical career that fits your goals and lifestyle.

Best Scientists Citing Taofeek K. Owonikoko

Trending Scientists

Recently Published Articles